Recent advances in therapy of chronic lymphocytic leukaemia.

Recent advances in therapy of chronic lymphocytic leukaemia.

Item
http://www.wikidata.org/entity/Q38862525
Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number.Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells.In Vitro Apoptotic Effects of Farnesyltransferase blockade in Acute Myeloid Leukemia Cells.Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey.Targeted therapy in the treatment of chronic lymphocytic leukemia: facts, shortcomings and hopes for the future.Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome.Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent.Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia
P2860

Recent advances in therapy of chronic lymphocytic leukaemia.

Item
http://www.wikidata.org/entity/Q38862525
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Recent advances in therapy of chronic lymphocytic leukaemia.
@en
type
label
Recent advances in therapy of chronic lymphocytic leukaemia.
@en
prefLabel
Recent advances in therapy of chronic lymphocytic leukaemia.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Recent advances in therapy of chronic lymphocytic leukaemia.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921